FDA Inspection 889603 — Center for Reproductive Medicine

Center for Reproductive Medicine — FEI 3005950704

The FDA completed an inspection of Center for Reproductive Medicine on July 31, 2014 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 31, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Minneapolis, MN (United States)